Paraganglioma of the Head and Neck: A Review
- PMID: 36252779
- PMCID: PMC9979593
- DOI: 10.1016/j.eprac.2022.10.002
Paraganglioma of the Head and Neck: A Review
Erratum in
-
Corrigendum to "Paraganglioma of the Head and Neck: A Review" [Endocrine Practice 29(2) (2023) Pages 141-147].Endocr Pract. 2024 Aug;30(8):790. doi: 10.1016/j.eprac.2024.06.005. Epub 2024 Jun 25. Endocr Pract. 2024. PMID: 38934984 No abstract available.
Abstract
Objective: To review the epidemiology, presentation, diagnosis, and management of head and neck paragangliomas.
Methods: A literature review of english language papers with focus on most current literature.
Results: Paragangliomas (PGLs) are a group of neuroendocrine tumors that arise in the parasympathetic or sympathetic ganglia. Head and neck PGLs (HNPGLs) comprise 65% to 70% of all PGLs and account for 0.6% of all head and neck cancers. The majority of HNPGLs are benign, and 6% to 19% of all HNPGLs develop metastasis outside the tumor site and significantly compromise survival. PGLs can have a familial etiology with germline sequence variations in different susceptibility genes, with the gene encoding succinate dehydrogenase being the most common sequence variation, or they can arise from somatic sequence variations or fusion genes. Workup includes biochemical testing to rule out secretory components, although it is rare in HNPGLs. In addition, imaging modalities, such as computed tomography and magnetic resonance imaging, help in monitoring in surgical planning. Functional imaging with DOTATATE-positron emission tomography, 18F-fluorodeoxyglucose, or 18F-fluorohydroxyphenylalanine may be necessary to rule out sites of metastases. The management of HNPGLs is complex depending on pathology, location, and aggressiveness of the tumor. Treatment ranges from observation to resection to systemic treatment. Similarly, the prognosis ranges from a normal life expectancy to a 5-year survival of 11.8% in patients with distant metastasis.
Conclusion: Our review is a comprehensive summary of the incidence, mortality, pathogenesis, presentation, workup and management of HNPGLs.
Keywords: head and neck neoplasms; neuroendocrine tumors; paraganglioma.
Copyright © 2022 AACE. All rights reserved.
Figures



References
-
- Erickson D, Kudva YC, Ebersold MJ, et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab. 2001;86(11):5210–5216. - PubMed
-
- Cass ND, Schopper MA, Lubin JA, Fishbein L, Gubbels SP. The changing paradigm of head and neck paragangliomas: what every otolaryngologist needs to know. Ann Otol Rhinol Laryngol. 2020;129(11):1135–1143. - PubMed
-
- Pellitteri PK, Rinaldo A, Myssiorek D, et al. Paragangliomas of the head and neck. Oral Oncol. 2004;40(6):563–575. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous